| 2:00pm |
|
Commentator Panel: Medical leaders provide their perspectives on opiate treatment and anchor an audience discussion – Hosack Hall
Moderator: Alan R. Fleischman , M.D., Senior Vice President, The New York Academy of Medicine
David C. Lewis, M.D., Director, Center for Alcohol & Addiction Studies, Brown University, Providence, Rhode Island
Martin Schechter, M.D., Ph.D., Faculty of Medicine, University of British Columbia
Alex Wodak, M.D. Director, Alcohol & Drug Service, St. Vincent's Hospital, Sydney, Australia
|
| 3:30pm |
|
Concurrent Focus Sessions:
1) Clinical and Treatment Issues – Room 20
Moderator/Presenter: David Marsh, M.D., Clinical Director, Addiction Medicine and Mental Health Services Corporation, Toronto, Canada
Tony Berthel, M.D., Director, Alcohol and Chemical Dependency Programs, Kantonsspital, Winterthur, Switzerland
Robert Haemmig, M.D., KODA-1, Bern, Switzerland
William Shanahan, M.D., Lead Clinician, Drug Dependency Unity, Chelsea and Westminster Hospital, London, Great Britain
2) Research and Evaluation – Room 21
Moderators: Ambros Uchtenhagen, M.D., Ph.D., Principal Investigator, Swiss National Project on the Medically Controlled Prescription of Narcotics
Nicola Metrebian, Research Fellow, Center for Research on Drugs and Health Behavior, Imperial College School of Medicine, London, Great Britain
Martin Schechter, M.D., Ph.D., Faculty of Medicine, University of British Columbia
Thomas Perneger, Ph.D., Medical Epidemiologist, Institute of Social and Preventative Medicine, University of Geneva Medical School, Geneva, Switzerland
Wim van den Brink, M.D., Ph.D., Chairman, Dutch Health Council Committee on Medicinal Intervention in Drug Addiction, The Netherlands
Maria Victoria Zunzunegui, Ph.D., Principal Investigator, School of Public Health, Anduluza, Granada, Spain
3) Legal/Policy Strategies – Room 440
Moderator: Ernest Drucker, Ph.D., Professor of Epidemiology and Social Medicine, Montefiore Medical Center, Bronx, New York
Gabriele Bammer, Ph.D., Senior Fellow, National Centre for Epidemiology and Population Health, Australian National University, Australia
Thomas Zeltner, Ph.D., Director, Swiss Federal Office of Public Health, Switzerland
Michael O'Shaughnessy, Ph.D., Director, British Columbia Center for Excellence in HIV/AIDS, Vancouver, Canada
|
